Reneo Pharmaceuticals Inc. is a biopharmaceutical company that focuses on developing innovative therapies for patients suffering from rare genetic diseases. Their research focuses on identifying and targeting specific molecular pathways to address the underlying cause of these diseases. With a dedicated team of researchers and a strong pipeline of potential treatments, Reneo Pharmaceuticals is poised to make a significant impact in the field of rare disease therapeutics.
